340 related articles for article (PubMed ID: 21666690)
41. Unappreciated diversity within the pool of CD1d-restricted T cells.
Pellicci DG; Uldrich AP
Semin Cell Dev Biol; 2018 Dec; 84():42-47. PubMed ID: 29183709
[TBL] [Abstract][Full Text] [Related]
42. The molecular bases of δ/αβ T cell-mediated antigen recognition.
Pellicci DG; Uldrich AP; Le Nours J; Ross F; Chabrol E; Eckle SB; de Boer R; Lim RT; McPherson K; Besra G; Howell AR; Moretta L; McCluskey J; Heemskerk MH; Gras S; Rossjohn J; Godfrey DI
J Exp Med; 2014 Dec; 211(13):2599-615. PubMed ID: 25452463
[TBL] [Abstract][Full Text] [Related]
43. TCR beta chain influences but does not solely control autoreactivity of V alpha 14J281T cells.
Gui M; Li J; Wen LJ; Hardy RR; Hayakawa K
J Immunol; 2001 Dec; 167(11):6239-46. PubMed ID: 11714786
[TBL] [Abstract][Full Text] [Related]
44. Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy.
Wu TN; Lin KH; Chang YJ; Huang JR; Cheng JY; Yu AL; Wong CH
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17275-80. PubMed ID: 21987790
[TBL] [Abstract][Full Text] [Related]
45. Human NKT cells express granulysin and exhibit antimycobacterial activity.
Gansert JL; Kiessler V; Engele M; Wittke F; Röllinghoff M; Krensky AM; Porcelli SA; Modlin RL; Stenger S
J Immunol; 2003 Mar; 170(6):3154-61. PubMed ID: 12626573
[TBL] [Abstract][Full Text] [Related]
46. The ins and outs of type I iNKT cell development.
Shissler SC; Webb TJ
Mol Immunol; 2019 Jan; 105():116-130. PubMed ID: 30502719
[TBL] [Abstract][Full Text] [Related]
47. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
Lang GA; Exley MA; Lang ML
Immunology; 2006 Sep; 119(1):116-25. PubMed ID: 16792697
[TBL] [Abstract][Full Text] [Related]
48. A novel recognition motif of human NKT antigen receptor for a glycolipid ligand.
Kawano T; Tanaka Y; Shimizu E; Kaneko Y; Kamata N; Sato H; Osada H; Sekiya S; Nakayama T; Taniguchi M
Int Immunol; 1999 Jun; 11(6):881-7. PubMed ID: 10360961
[TBL] [Abstract][Full Text] [Related]
49. Introduction of aromatic group on 4'-OH of α-GalCer manipulated NKT cell cytokine production.
Zhang W; Xia C; Nadas J; Chen W; Gu L; Wang PG
Bioorg Med Chem; 2011 Apr; 19(8):2767-76. PubMed ID: 21439833
[TBL] [Abstract][Full Text] [Related]
50. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size.
Matsuda JL; Gapin L; Fazilleau N; Warren K; Naidenko OV; Kronenberg M
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12636-41. PubMed ID: 11592984
[TBL] [Abstract][Full Text] [Related]
51. Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.
Li X; Fujio M; Imamura M; Wu D; Vasan S; Wong CH; Ho DD; Tsuji M
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13010-5. PubMed ID: 20616071
[TBL] [Abstract][Full Text] [Related]
52. Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors.
Gadola SD; Koch M; Marles-Wright J; Lissin NM; Shepherd D; Matulis G; Harlos K; Villiger PM; Stuart DI; Jakobsen BK; Cerundolo V; Jones EY
J Exp Med; 2006 Mar; 203(3):699-710. PubMed ID: 16520393
[TBL] [Abstract][Full Text] [Related]
53. Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy.
Weinkove R; Brooks CR; Carter JM; Hermans IF; Ronchese F
Haematologica; 2013 Mar; 98(3):376-84. PubMed ID: 23065503
[TBL] [Abstract][Full Text] [Related]
54. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
55. Artificial antigen presenting cell (aAPC) mediated activation and expansion of natural killer T cells.
East JE; Sun W; Webb TJ
J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299308
[TBL] [Abstract][Full Text] [Related]
56. Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells.
Zajonc DM; Kronenberg M
Immunol Rev; 2009 Jul; 230(1):188-200. PubMed ID: 19594637
[TBL] [Abstract][Full Text] [Related]
57. CD1d-lipid antigen recognition by the γδ TCR.
Uldrich AP; Le Nours J; Pellicci DG; Gherardin NA; McPherson KG; Lim RT; Patel O; Beddoe T; Gras S; Rossjohn J; Godfrey DI
Nat Immunol; 2013 Nov; 14(11):1137-45. PubMed ID: 24076636
[TBL] [Abstract][Full Text] [Related]
58. Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation.
Im JS; Arora P; Bricard G; Molano A; Venkataswamy MM; Baine I; Jerud ES; Goldberg MF; Baena A; Yu KO; Ndonye RM; Howell AR; Yuan W; Cresswell P; Chang YT; Illarionov PA; Besra GS; Porcelli SA
Immunity; 2009 Jun; 30(6):888-98. PubMed ID: 19538930
[TBL] [Abstract][Full Text] [Related]
59. Antigen Specificity of Type I NKT Cells Is Governed by TCR β-Chain Diversity.
Cameron G; Pellicci DG; Uldrich AP; Besra GS; Illarionov P; Williams SJ; La Gruta NL; Rossjohn J; Godfrey DI
J Immunol; 2015 Nov; 195(10):4604-14. PubMed ID: 26423148
[TBL] [Abstract][Full Text] [Related]
60. CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosis.
Schneiders FL; Prodöhl J; Ruben JM; O'Toole T; Scheper RJ; Bonneville M; Scotet E; Verheul HM; de Gruijl TD; van der Vliet HJ
Cancer Immunol Res; 2014 Aug; 2(8):732-40. PubMed ID: 24934445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
